Publications
13
Citations
971
Est. group size
—
Recurring co-author estimate
Active years
37
Publishing since 1988
Anna Leone's publicly available bibliographic record is very limited, making it difficult to characterize a clear research program. The one identifiable recent publication concerns real-world use of risankizumab, a biologic drug, for treating Crohn's disease, an inflammatory bowel condition. The listed OpenAlex topic tags (covering areas like nitric oxide biology, circadian rhythms, sleep and respiration, HIV complications, and asthma) show no relevance scores, suggesting these associations are weak or uncertain.
Publication output has been minimal and sporadic over the last decade, with activity only appearing in 2023 and 2024.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- S1069 Early Observations in the Real-World Use of Risankizumab Therapy for Crohn’s Disease
The American Journal of Gastroenterology · 2024
- Gastroenterology×2
- The American Journal of Gastroenterology×1
- Jason A. Scott
Medicine · Purdue University West Lafayette
- Craig Hemann
Medicine · The Ohio State University
- Elsayed M. Mahgoup
Medicine · The Ohio State University
- Bhavani Gopalakrishnan
Medicine · Purdue University West Lafayette
- Mohamed A. El‐Mahdy
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile